Biohit Oyj
Develops diagnostic products for early disease detection, focusing on gastroenterology.
BIOBV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009005482
- LEI:
- 74370089ATTSNBXJVT29
- Country:
- Finland
- Address:
- LAIPPATIE 1, FI-00880 HELSINKI
- Sector:
- Manufacturing
Description
Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2013-02-27 07:30 |
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2012
|
Finnish | HTML • 36.6 KB | ||
| 2013-02-27 07:30 |
BIOHIT GROUP FINANCIAL STATEMENT RELEASE 2012
|
English | HTML • 38.0 KB | ||
| 2013-02-11 15:00 |
Biohit Oyj and Tamro Oyj agreed to tighten co-operation concerning Acetium prod…
|
Finnish | HTML • 9.3 KB | ||
| 2013-02-11 15:00 |
Biohit Oyj and Tamro Oyj agreed to tighten co-operation concerning Acetium prod…
|
English | HTML • 8.9 KB | ||
| 2013-01-29 07:30 |
Biohit continues the clinical study, the purpose of which is to determine the c…
|
Finnish | HTML • 15.9 KB | ||
| 2013-01-29 07:30 |
Biohit continues the clinical study, the purpose of which is to determine the c…
|
English | HTML • 15.4 KB | ||
| 2013-01-22 09:00 |
CORRECTION TO KAUPPALEHTI ARTICLE
|
Finnish | HTML • 1.1 KB | ||
| 2013-01-22 09:00 |
CORRECTION TO KAUPPALEHTI ARTICLE
|
English | HTML • 1.1 KB | ||
| 2013-01-09 08:00 |
Biohit signs licensing agreement with GrandPharma
|
Finnish | HTML • 17.0 KB | ||
| 2013-01-09 08:00 |
Biohit signs licensing agreement with GrandPharma
|
English | HTML • 16.1 KB | ||
| 2012-12-28 14:00 |
Biohit signs distribution agreement with Xediton
|
Finnish | HTML • 16.7 KB | ||
| 2012-12-28 14:00 |
Biohit signs distribution agreement with Xediton
|
English | HTML • 15.8 KB | ||
| 2012-12-20 10:30 |
Biohit announces results from acetaldehyde measurements
|
English | HTML • 5.6 KB | ||
| 2012-12-11 08:30 |
Biohit's Financial Reporting and Annual General Meeting in 2013
|
Finnish | HTML • 2.2 KB | ||
| 2012-12-11 08:30 |
Biohit's Financial Reporting and Annual General Meeting in 2013
|
English | HTML • 2.2 KB |
Automate Your Workflow. Get a real-time feed of all Biohit Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biohit Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biohit Oyj via our API.
Peer Companies
